Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru

Trial Profile

Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru

Completed
Phase of Trial: Phase III

Latest Information Update: 30 May 2014

At a glance

  • Drugs CYD TDV (Primary) ; Yellow fever vaccine
  • Indications Dengue; Yellow fever
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Sep 2013 Planned end date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 05 Feb 2013 Planned End Date changed from 1 Jan 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top